Larimar Therapeutics, Inc. (LRMR) Earnings Per Share (EPS)
Larimar Therapeutics, Inc. (LRMR) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | -$3.57 |
| 2021-12-31 | -$2.95 |
| 2022-12-31 | -$1.37 |
| 2023-12-31 | -$0.84 |
| 2024-12-31 | -$1.32 |
| 2025-12-31 | -$2.27 |
How LRMR compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| VERU | Veru Inc. | -$1.55 |
| VTGN | Vistagen Therapeutics Inc. | -$1.83 |
| HSDT | Helius Medical Technologies Inc. | -$1.85 |
| VYGR | Voyager Therapeutics Inc. | -$2.04 |
| PMCB | PharmaCyte Biotech Inc. | -$2.77 |
These are five companies in the same sector as LRMR with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Larimar Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("LRMR")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | LRMR | $3.94 | +3.14% | 0.76M |
| 3 | ||||
| 4 | ||||
| 5 |